Naturhouse Health SA
Naturhouse Health SA operates in the retail sector, specializing in health and wellness products, and generates revenue primarily through the sale of these products to consumers.
Business. Naturhouse Health SA (NTH.MC) is a miscellaneous specialty retailer headquartered in Spain and listed on the BME (Madrid) exchange. The company operates within the Consumer Cyclicals sector, generating revenue primarily through product sales. Specific details regarding operating segments and geographic breakdowns are not provided in the available data.
At a glance
What drives this business
The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.
News & coverage
0Sector rotation
Developing storylines
Analysis
AI analysisOpportunity
Upcoming catalysts
Scheduled public events. Informational only — not investment advice.
- Macro
- Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
- Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
- Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
- Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
- Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
- Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
- Macro & political
- ElectionSE Swedish Election2026-09-14 · SE
- ElectionUS U.S. Midterms2026-11-03 · US
- ElectionFR French Legislative2027-06-01 · FR
Pre-earnings brief
Signals & dispatch
Composite-score breakdown
Synthesis
Naturhouse Health SA (NTH.MC) is a miscellaneous specialty retailer headquartered in Spain and listed on the BME (Madrid) exchange. The company operates within the Consumer Cyclicals sector, generating revenue primarily through product sales. Specific details regarding operating segments and geographic breakdowns are not provided in the available data.
Naturhouse Health SA maintains a strong liquidity position, with a current ratio of 1.65, indicating the company can cover its short-term liabilities with its short-term assets. The company's liquidity_fpt score further supports this, showing a low liquidity risk. However, the company's free cash flow is negative at -6.522 million EUR, which may indicate that capital expenditures and other operational costs are outpacing cash inflows.
In terms of profitability, Naturhouse Health SA demonstrates a return on equity of 56.86% and a return on assets of 30.19%, both of which are strong indicators of efficient use of equity and assets to generate profit. The company's operating income of 13.418 million EUR and net income of 10.094 million EUR suggest a healthy margin, although the exact comparison to industry medians is not provided in the available data.
The company's revenue is not segmented by product or geographic region in the provided data, so the extent of revenue concentration in specific segments or regions cannot be determined. However, the company's operations are likely concentrated in the European market, given the EUR financial reporting and the company's listing on the Madrid Stock Exchange.
Looking at the growth trajectory, the company's revenue for the latest period is reported at 47.629 million EUR, and the analyst estimate for the last actual revenue is 49.425 million EUR, suggesting a slight positive growth trend. The outlook for the current and next fiscal years is not explicitly provided, but the company's strong profitability and liquidity position may support continued growth.
The risk assessment indicates a low risk of dilution and no immediate filing-based liquidity or dilution flags were detected. The company's debt to equity ratio of 0.14 suggests a conservative capital structure with minimal long-term debt, which reduces financial risk.
Recent events, such as filings or transcripts, are not detailed in the provided data, so no specific recent developments can be cited. However, the company's financial health and low risk profile suggest that it is well-positioned to navigate potential market challenges.
- Naturhouse Health SA has a strong liquidity position with a current ratio of 1.65.
- The company demonstrates high profitability with a return on equity of 56.86% and a return on assets of 30.19%.
- The company's capital structure is conservative, with a low debt to equity ratio of 0.14.
- The company's free cash flow is negative, indicating that capital expenditures and operational costs are outpacing cash inflows.
- The company has a low risk of dilution and no immediate filing-based liquidity or dilution flags were detected.
- "margin_outlook_rationale": "The company's strong profitability, as indicated by its high return on equity and return on assets, suggests that margins are likely to remain stable or improve in the near term.",
Bull / Bear case
Generated · model-assistedIn focus — financials by report
Valuation
Revenue by segment
Business relationships
Supply chain
Peer comparison
Market position
Stress test
Predictor forecast
Options
Short squeeze
Earnings-call key lines
Estimate revisions
consensus EPS · 26-week trendSell-side observations
Themes
ESG
Risk factors
- No immediate filing-based liquidity or dilution flags were detected.
Benchmarks vs cohort
Corporate actions / M&A
FX exposure
Comparable transactions
Derivatives & instruments
Actions
Ask Handelsavisen
- Market data
- Market data cache
- Issuer disclosures
- Public news
- Earnings transcripts
- Consensus estimates
- ESG data
- Dilution Ratio(shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
- Net Cashcash_and_equivalents + short_term_investments - short_term_debt - long_term_debt
- Capex To Revenuecapital_expenditure / revenue
- Return On Equitynet_income / total_equity
- Debt To Equity(short_term_debt + long_term_debt) / total_equity
- Cash Conversion Ratiooperating_cash_flow / net_income
- Naturhouse Health SA Market data — financials · 2026-05-28
- Naturhouse Health SA Market data — analyst estimates · 2026-05-28